137 related articles for article (PubMed ID: 27145964)
21. Gene Amplification of Mediator Subunit 30 Redirects the MYC Transcriptional Program and Oncogenesis.
Jin C; Zhao L; Zhao G; Liu Y; Ma W; Ma S; Yao L; Liu Y; Wu Q; Yuan H; Yang K; Ohgi K; Rich JN; Rosenfeld MG
Res Sq; 2024 May; ():. PubMed ID: 38766212
[TBL] [Abstract][Full Text] [Related]
22. Palmitoyl transferase ZDHHC20 promotes pancreatic cancer metastasis.
Tomić G; Sheridan C; Refermat AY; Baggelaar MP; Sipthorp J; Sudarshan B; Ocasio CA; Suárez-Bonnet A; Priestnall SL; Herbert E; Tate EW; Downward J
Cell Rep; 2024 May; 43(5):114224. PubMed ID: 38733589
[TBL] [Abstract][Full Text] [Related]
23. Roles of the nervous system in pancreatic cancer.
Wakiya T; Ishido K; Yoshizawa T; Kanda T; Hakamada K
Ann Gastroenterol Surg; 2021 Sep; 5(5):623-633. PubMed ID: 34585047
[TBL] [Abstract][Full Text] [Related]
24. Intron retention is a robust marker of intertumoral heterogeneity in pancreatic ductal adenocarcinoma.
Tan DJ; Mitra M; Chiu AM; Coller HA
NPJ Genom Med; 2020 Dec; 5(1):55. PubMed ID: 33311498
[TBL] [Abstract][Full Text] [Related]
25. Khasianine Affects the Expression of Sugar-Sensitive Proteins in Pancreatic Cancer Cells, Which Are Altered in Data from the Rat Model and Patients.
Sagini MN; Klika KD; Owen RW; Berger MR
ACS Pharmacol Transl Sci; 2023 May; 6(5):727-737. PubMed ID: 37200805
[TBL] [Abstract][Full Text] [Related]
26. Trends and hotspots of prognostic factors for pancreatic ductal adenocarcinoma from 2013 to 2022.
Peng J; Lv M; Peng Y; Tang X
Hepatobiliary Surg Nutr; 2024 Apr; 13(2):370-373. PubMed ID: 38617492
[No Abstract] [Full Text] [Related]
27. Ephexin3/ARHGEF5 Together with Cell Migration Signaling Partners within the Tumor Microenvironment Define Prognostic Transcriptional Signatures in Multiple Cancer Types.
Juan-Guadarrama DG; Beltrán-Navarro YM; Reyes-Cruz G; Vázquez-Prado J
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003617
[TBL] [Abstract][Full Text] [Related]
28. Mutations in ARHGEF15 cause autosomal dominant hereditary cerebral small vessel disease and osteoporotic fracture.
Ding X; Chen Y; Guo C; Fu Y; Qin C; Zhu Q; Wang J; Zhang R; Tian H; Feng R; Liu H; Liang D; Wang G; Teng J; Li J; Tang B; Wang X
Acta Neuropathol; 2023 May; 145(5):681-705. PubMed ID: 36929019
[TBL] [Abstract][Full Text] [Related]
29. FRL: An Integrative Feature Selection Algorithm Based on the Fisher Score, Recursive Feature Elimination, and Logistic Regression to Identify Potential Genomic Biomarkers.
Ge C; Luo L; Zhang J; Meng X; Chen Y
Biomed Res Int; 2021; 2021():4312850. PubMed ID: 34235216
[TBL] [Abstract][Full Text] [Related]
30. Sulfite Oxidase Is a Novel Prognostic Biomarker of Advanced Gastric Cancer.
Yano Y; Akiba J; Naito Y; Sadashima E; Cho H; Hishima T; Yano H
In Vivo; 2021; 35(1):229-237. PubMed ID: 33402469
[TBL] [Abstract][Full Text] [Related]
31. Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Primary and Recurrent Meningioma.
Zhang H; Qi L; Du Y; Huang LF; Braun FK; Kogiso M; Zhao Y; Li C; Lindsay H; Zhao S; Injac SG; Baxter PA; Su JM; Stephan C; Keller C; Heck KA; Harmanci A; Harmanci AO; Yang J; Klisch TJ; Li XN; Patel AJ
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32517016
[TBL] [Abstract][Full Text] [Related]
32. FARP1 boosts CDC42 activity from integrin αvβ5 signaling and correlates with poor prognosis of advanced gastric cancer.
Hirano T; Shinsato Y; Tanabe K; Higa N; Kamil M; Kawahara K; Yamamoto M; Minami K; Shimokawa M; Arigami T; Yanagita S; Matushita D; Uenosono Y; Ishigami S; Kijima Y; Maemura K; Kitazono I; Tanimoto A; Furukawa T; Natsugoe S
Oncogenesis; 2020 Feb; 9(2):13. PubMed ID: 32029704
[TBL] [Abstract][Full Text] [Related]
33. Emerging Roles of Ephexins in Physiology and Disease.
Kim K; Lee SA; Park D
Cells; 2019 Jan; 8(2):. PubMed ID: 30682817
[TBL] [Abstract][Full Text] [Related]
34. High sulfite oxidase expression could predict postoperative biochemical recurrence in patients with prostate cancer.
Kurose H; Naito Y; Akiba J; Kondo R; Ogasawara S; Kusano H; Sanada S; Abe H; Kakuma T; Ueda K; Igawa T; Yano H
Med Mol Morphol; 2019 Sep; 52(3):164-172. PubMed ID: 30631948
[TBL] [Abstract][Full Text] [Related]
35. A dual role for the RhoGEF Ephexin5 in regulation of dendritic spine outgrowth.
Hamilton AM; Lambert JT; Parajuli LK; Vivas O; Park DK; Stein IS; Jahncke JN; Greenberg ME; Margolis SS; Zito K
Mol Cell Neurosci; 2017 Apr; 80():66-74. PubMed ID: 28185854
[TBL] [Abstract][Full Text] [Related]
36. ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of the cancer cells.
Fukushima H; Yasumoto M; Ogasawara S; Akiba J; Kitasato Y; Nakayama M; Naito Y; Ishida Y; Okabe Y; Yasunaga M; Horiuchi H; Sakamoto E; Itadani H; Mizuarai S; Oie S; Yano H
Mol Cancer; 2016 May; 15(1):32. PubMed ID: 27145964
[TBL] [Abstract][Full Text] [Related]
37. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
38. High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC).
Gong C; Zhang Y; Chen Y; Zhang H; Liu X; Xue H; Ji L; Wang L; Yang L; Zhou G; Wan C
Tumour Biol; 2015 Dec; 36(12):9189-99. PubMed ID: 26088450
[TBL] [Abstract][Full Text] [Related]
39. Upregulated long noncoding RNA LINC01296 indicates a dismal prognosis for pancreatic ductal adenocarcinoma and promotes cell metastatic properties by affecting EMT.
Yuan Q; Zhang Y; Feng L; Jiang Y
J Cell Biochem; 2019 Jan; 120(1):552-561. PubMed ID: 30203487
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological significance and prognostic role of chemokine receptor CXCR4 expression in pancreatic ductal adenocarcinoma, a meta-analysis and literature review.
Ding Y; Du Y
Int J Surg; 2019 May; 65():32-38. PubMed ID: 30902754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
